Chronic Myeloid Leukemia‎

Monitoring Disease Recurrence With Patient-Reported Outcomes After Discontinuation of Tyrosine Kinase Inhibitor Therapy

By

Tiffany Garbutt, PhD

Publish Date December 10, 2019

Results of LAST, the largest study on TKI discontinuation, support using patient-reported outcomes when monitoring remission and symptoms in patients who discontinue TKI therapy.

Follow-Up Results of Low-Dose Dasatinib for Chronic-Phase Chronic Myeloid Leukemia

By

Vicki Moore, PhD

Publish Date October 28, 2019

Patients received 50 mg dasatinib daily and demonstrated 2-year rates of overall and event-free survival of 100%.

Adherence to Other Oral Medications Declines Following Introduction of Oral Oncolytics

By

Susan Moench, PhD, PA-C

Publish Date October 25, 2019

This study assessed levels of adherence to antihypertensive, lipid-lowering, and antidiabetic therapy in patients initiating oral oncology therapy for a hematologic cancer.

The Disappointing Reality of Crowdfunding Cancer Care

By

Sarah Elizabeth Richards

Publish Date October 22, 2019

If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.

Some Targeted Therapies May Miss the Mark

By

Caroline Seydel

Publish Date October 17, 2019

Ten different drugs continued to kill cancer cells even when their target proteins were removed.

Leukemia Clinical Trials

Clinical Trial: Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical trial focusing on the molecular epidemiology of childhood leukemia. Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical Trial: Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical trial focusing on genetics and chronic lymphocytic leukemia. Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical Trial: Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical trial focusing on vaccine generation from chronic lymphocytic leukemia tumor cells. Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical Trial: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical trial focusing on GNKG168. Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical Trial: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Clinical trial focusing on carfilzomib Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL). Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) .